Amedisys

Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, and Personal Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The company was founded by William F. Borne in 1982 and is headquartered in Baton Rouge, LA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Amedisys reports robust Q4 earnings, eyes growth amidst operational challenges

Amedisys showcases strong financial performance and strategic initiatives for 2023, focusing on growth and operational optimization.
Despite challenges like labor market issues and operational hurdles, the company remains confident in its growth strategies and talent management.
Opportunities in negotiations with payers, talent acquisition, and operational enhancements position Amedisys for continued success and revenue growth.
With a positive outlook for 2023 and a resilient approach to challenges, Amedisys is poised for steady growth and operational improvements.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The High Acuity Care segment includes providing home care recovery for high acuity patients on either a full risk or limited risk basis. The company was founded in 1982 and is headquartered in Baton Rouge, LA.

Amedisys is expected to report earnings on Jul. 28. Amedisys now trading 2% below the 218.54 buy point from a fourth-stage consolidation that it cleared earlier.

Stocks To Watch With Earnings On Deck: Amedisys

Amedisys (AMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Amedisys (AMED) Expected to Beat Earnings Estimates: Should You Buy?

Amedisys (AMED) while seeing a drop in MIS visits is experiencing steady recovery in referral volumes.

Amedisys Rides on Coronavirus-Led Business Amid Cost Woes

BATON ROUGE, La., July  16, 2020  (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), announced today that it will report results for the second quarter ended June 30, 2020, after the market closes on July 28, 2020. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on July 29, 2020.

Amedisys Announces Second Quarter Earnings Release and Conference Call Date

Amedisys (AMED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why the Earnings Surprise Streak Could Continue for Amedisys (AMED)

Fortinet

Lululemon Athletica

Costco

Inphi

Lululemon, Fortinet, Inphi, Costco Wholesale and Amedisys are leading stocks to watch, all in or near buy zones.

Lululemon, Fortinet Lead 5 Top Stocks In Or Near Buy Zones

Addus HomeCare

ADUS vs. AMED: Which Stock Is the Better Value Option?

Amedisys (AMED) benefits from the recent acquisitions of hospice care providers, Asana Hospice, RoseRock Healthcare and Compassionate Care Hospice.

Amedisys Rides on Hospice Arm Expansion Amid Coronavirus Woes

Quest Diagnostics

DGX vs. AMED: Which Stock Is the Better Value Option?

BATON ROUGE, La., June  17, 2020  (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the 2020 BMO Prescriptions for Success Healthcare Conference on Tuesday, June 23, 2020.

Amedisys to Present at the BMO 2020 Prescriptions for Success Healthcare Conference

BioMarin Pharmaceutical

Haemonetics

Horizon Pharma

Zimmer Biomet Hlds

With the first half of what has proven to be a remarkable 2020 coming to a close, many of the firms we cover across Wall Street already are looking to the second half of the year, with what should be an improving economy as we emerge from the COVID-19 pandemic lockdowns.

Jefferies 5 High-Conviction Health Care Stocks to Buy for the Second Half

Amedisys (AMED) reported earnings 30 days ago. What's next for the stock?

Amedisys (AMED) Up 2.5% Since Last Earnings Report: Can It Continue?

BATON ROUGE, La., June  05, 2020  (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the 40th Annual William Blair Growth Stock Conference on Wednesday, June 10, 2020.

Amedisys to Present at the 40th Annual William Blair Growth Stock Conference

Amedisys (AMED) expects AseraCare business to add greater scale to its existing nationwide network.

Amedisys (AMED) Broadens Hospice Base With AseraCare Buyout

BATON ROUGE, La., June  01, 2020  (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), a leading provider of home health, hospice and personal care, announced today that, through one of its wholly owned subsidiaries, it has closed on its acquisition of Homecare Preferred Choice, Inc., doing business as AseraCare Hospice (“AseraCare Hospice” or “AseraCare”), a national hospice care provider with an executive office in Plano, Texas and administrative support center in Fort Smith, Arkansas.

Amedisys Completes Acquisition of AseraCare Hospice

Brookdale Senior Living

Chemed

Ensign Group

There are approximately 35 million Americans aged 65 or older currently and this number is expected to double in the next 25 years.

Silver Tsunami to Hit the United States: 4 Stocks in Focus

Amedisys, Inc. (AMED) CEO Paul Kusserow on Q1 2020 Results - Earnings Call Transcript

Amedisys (AMED) notes that COVID-19 started impacting its volumes and costs beginning the second half of March.

Amedisys (AMED) Q1 Earnings Beat, Operating Margin Falls

Amedisys (AMED) delivered earnings and revenue surprises of 8.25% and -4.02%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Amedisys (AMED) Beats Q1 Earnings Estimates

Atmos Energy

Franco-Nevada C

NextEra Energy

With the earnings season in full swing, the real challenge for an investor is determining whether an organization's debt level is sustainable.

Bet on These 5 Low Leverage Stocks to Avoid Huge Losses

BATON ROUGE, La., May  01, 2020  (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of the nation’s leading home healthcare, hospice and personal care companies, celebrates National Nurses Month by honoring more than 8,000 nurses who call the company home.

Amedisys Celebrates More Than 8,000 Nurses During National Nurses Month

Baxter

Jack Henry & Associates

Johnson & Johnson

Verizon

Verizon Communications Inc 5.9 % Notes 2014-15.2.54 Sr

It’s been 100 years since the United States and the world has encountered a pandemic like COVID-19.

5 Stocks to Buy Now for a W-Shaped Recovery With a Long Recession

Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Amedisys (AMED) Q1 Earnings Expected to Decline

ACADIA Pharma

Biogen

Boyd Gaming

Hill-Rom Hlds

Royal Caribbean Cruises

Teladoc

Thor Industries

UnitedHealth Group

Ventas

Aging seniors have been put firmly in the crosshairs of the novel coronavirus. These 10 stocks to buy will benefit from this brutal reality.

10 Stocks to Buy for an Aging Population

BATON ROUGE, La., April  27, 2020  (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), a leading provider of home health, hospice and personal care, announced today that it has, through one of its wholly owned subsidiaries, signed a definitive agreement to acquire Homecare Preferred Choice, Inc., doing business as AseraCare Hospice (“AseraCare Hospice”), a national hospice care provider with an executive office in Plano, Texas and administrative support center in Fort Smith, Arkansas. Founded in 1994, AseraCare Hospice cares for more than 2,100 patients daily and employs more than 1,200 hospice professionals in 44 locations across 14 states, generating approximately $117 million in annual revenues.

Amedisys Signs Definitive Agreement to Acquire AseraCare Hospice

News for Amedisys Stock (AMED)